Author:
Fu Zhijie,Pang Zhilu,He Long,Zhang Le,Fan Yuning,Zhao Can,Yang Jianjun
Publisher
Springer Science and Business Media LLC
Subject
Cellular and Molecular Neuroscience,General Medicine,Biochemistry
Reference38 articles.
1. Dahmani S, Paris A, Jannier V, Hein L, Rouelle D, Scholz J et al (2008) Dexmedetomidine increases hippocampal phosphorylated extracellular signalregulated protein kinase 1 and 2 content by an a 2-adrenoceptor-independent mechanism: evidence for the involvement of imidazoline I1 receptors. Anesthesiology 108:457–466
2. Engelhard K, Werner C, Eberspacher E, Bachl M, Blobner M, Hildt E et al (2003) The effect of the a2-agonist dexmedetomidine and the N-methyl-Daspartate antagonist S (+)-ketamine on the expression of apoptosis-regulating proteins after incomplete cerebral ischemia and reperfusion in rats. Anesth Analg 96:524–531
3. Dahmani S, Rouelle D, Gressens P, Mantz J (2010) Characterization of the postconditioning effect of dexmedetomidine in mouse organotypic hippocampal slice cultures exposed to oxygen and glucose deprivation. Anesthesiology 112:373–383
4. Cui J, Zhao H, Wang C, Sun JJ, Lu K, Ma D (2015) Dexmedetomidine attenuates oxidative stress induced lung alveolar epithelial cell apoptosis in vitro. Oxid Med Cell Longev 2015:358396
5. Gencer B, Karaca T, Tufan HA, Kara S, Arikan S, Toman H et al (2014) The protective effects of dexmedetomidine against apoptosis in retinal ischemia/reperfusion injury in rats. Cutan Ocul Toxicol 33:283–288
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献